Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

12.05USD
22 Apr 2019
Change (% chg)

$-0.02 (-0.17%)
Prev Close
$12.07
Open
$12.08
Day's High
$12.34
Day's Low
$11.93
Volume
132,347
Avg. Vol
235,883
52-wk High
$15.00
52-wk Low
$6.33

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 2.08
Market Cap(Mil.): $358.81
Shares Outstanding(Mil.): 43.76
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.06 -- --
ROI: -182.71 8.91 13.83
ROE: -308.78 10.06 15.25

Earnings vs. Estimates